Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1245.50

-24.30 (-1.91%)

< Home < Back

Clarification sought from Dr Reddys Laboratories

Date: 01-09-2017

The Exchange has sought clarification from Dr Reddys Laboratories on September 01, 2017 with reference to news flashed on http://www.thehindubusinessline.com dated September 01, 2017 quoting ‘Dr Reddys settles patent row with Vivus’.

The above information is a part of company’s filings submitted to BSE.